CAS: 65295-69-4; 2,6-Difluorophenylisocyanate

该化合物是一种氟芳烃异丙氰酸化合物,其特点是反应性异丙氰酸(-NCO)组和苯环1和3位置的两个氟替代物.这一结构使异丙氰酸盐组具有更强的电益性,使其成为聚氨酯,农用化学品和药物合成中的宝贵中间体.氟原子有助于提高化学稳定性和回活动性,并有可能改善衍生材料的热和氧化抗力.其精确分子结构允许选择性的功能化,使特殊化学应用的量身修改成为可能.该化合物通常在受控条件下处理,原因是其湿度敏感度和再活性.

结构式图片

欧盟法规

ECHA物质C&L通报

上下游产品

oxalyl dichloride 2,6-difluorobenzamide bis(trichloromethyl) carbonate 2,6-difluoroaniline N-(2,6-difluorophenyl)-3-(([(2,6-difluorophenyl)amino]carbonyl)amino)-1H-indazole-1-carboxamide 1-(2,6-difluorophenyl)-3-(4-((4-oxo-4H-pyrido[1,2-a]pyrimidin-2-yl)methoxy)phenyl)urea

合成工艺路线路线简述

    2,6-二氟苯甲酰胺置于草酰氯体系中,用 甲苯 作为反应溶剂,化学反应 3.0H,反应生成 2,6-二氟异氰酸苯酯
    参考文献:吡虫隆及其制备方法
    标题:吡虫隆及其制备方法
    摘要:本发明涉及一种杀虫剂吡虫隆的合成方法.该方法采用离子液体作为催化剂,以2,3二氯‑5‑三氟甲基吡啶,2‑氯‑5‑氨基苯酚,2,6‑二氟苯甲酰胺和草酰氯作为原料,在温和条件下合成吡虫隆.该方法工艺简单,安全性高,副反应少,反应时间短,收率高.使用该方法得到的吡虫隆的收率大于90%,纯度大于99%.

    海关参考信息

    专利信息


    专利号:US-2005192265-A1
    优先权日:2003-03-20
    标 题:Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
    发明人:THOMPSON RICHARD C; WILKIE STEPHEN; STACK DOUGLAS R; VANMETER ELDON E; SHI QING; BRITTON THOMAS C; AUDIA JAMES E; REEL JON K; MABRY THOMAS E; DRESSMAN BRUCE A; CWI CYNTHIA L; HENRY STEVEN S; MCDANIEL STACEY L; STUCKY RUSSELL D; PORTER WARREN J
    摘要:Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions that include a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

    专利号:US-6906056-B2
    优先权日:1998-06-22
    标 题:Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
    发明人:THOMPSON RICHARD C; WILKIE STEPHEN; STACK DOUGLAS R; VANMETER ELDON E; SHI QING; BRITTON THOMAS C; AUDIA JAMES E; REEL JON K; MABRY THOMAS E; DRESSMAN BRUCE A; CWI CYNTHIA L; HENRY STEVEN S; MCDANIEL STACEY L; STUCKY RUSSELL D; PORTER WARREN J
    权利人:LILLY CO ELI
    摘要:Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions that include a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

    专利号:US-2004106598-A1
    优先权日:1998-06-22
    标 题:Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting Beta-amyloid peptide release and/or its synthesis by use of such compounds

    专利号:US-2005192269-A1
    优先权日:1998-06-22
    标 题:Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds

    专利号:US-2005267150-A1
    优先权日:1998-06-22
    标 题:Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds

    专利号:US-2008293785-A1
    优先权日:2006-04-11
    标 题 :Substituted benzothiazole kinase inhibitors
    发明人:CONNOLLY PETER J; EMANUEL STUART L; HUANG SHENLIN; TURCHI IGNATIUS J
    权利人:CONNOLLY PETER J; EMANUEL STUART L; HUANG SHENLIN; TURCHI IGNATIUS J
    摘要:The present invention is directed to substituted benzothiazole compounds of formula (I): n n n n n n n n n n and forms thereof, their synthesis and use for treating a chronic or acute protein kinase mediated disease, disorder or condition.
    石家庄东智化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    电话:18032763683👤
    ⚠️参考联系方式
    邮件:dongzhihuagong@163.com
    销售经理: 王经理
    联系电话:18032763683
    传真号码: 13102890206
    QQ号:442112647
    裕华区工农路29号
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    裕华区工农路29号
    ⚠️ 未注册 · 未认证企业
    注册入口 声明: 数据来源:本内容基于各搜索引擎等公开数据整理,仅作展示用。请自行辨别 📄若企业需抹除相关内容或, 请联系方我们,我们即刻栓除。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1007/s00044-016-1523-0
    摘要:Wittine K, Ratkaj I, Benci K, Suhina T, Mandić L, Ilić N, Pavelić SK, Pavelić K, Mintas M. The novel coumarin[3,2-c]thiophene and its hydroxamic acid and ureido derivatives: synthesis and cytostatic activity evaluations. Medicinal Chemistry Research. 2016 Feb 17;25(4):728–37. doi: 10.1007/s00044-016-1523-0.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知